HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Susanta Mondal Selected Research

RNS60

1/2018Correction to: Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy.
5/2017Nebulization of RNS60, a Physically-Modified Saline, Attenuates the Adoptive Transfer of Experimental Allergic Encephalomyelitis in Mice: Implications for Multiple Sclerosis Therapy.
1/2012Protection of Tregs, suppression of Th1 and Th17 cells, and amelioration of experimental allergic encephalomyelitis by a physically-modified saline.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Susanta Mondal Research Topics

Disease

14Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
12/2023 - 04/2009
13Multiple Sclerosis
05/2024 - 04/2009
6Inflammation (Inflammations)
03/2024 - 01/2015
5Demyelinating Diseases (Demyelinating Disease)
11/2018 - 07/2012
4Parkinson Disease (Parkinson's Disease)
03/2022 - 01/2016
3Neurodegenerative Diseases (Neurodegenerative Disease)
03/2024 - 12/2019
3Neuroinflammatory Diseases
05/2019 - 07/2012
2Huntington Disease (Huntington's Disease)
03/2024 - 01/2016
2Inborn Urea Cycle Disorders
03/2022 - 10/2016
2Chronic Disease (Chronic Diseases)
11/2018 - 05/2017
1Heartburn (Pyrosis)
03/2024
1Pain (Aches)
03/2024
1Neoplasms (Cancer)
12/2023
1Pancreatic Neoplasms (Pancreatic Cancer)
12/2023
1Parkinsonian Disorders (Parkinsonism)
03/2022
1Nonketotic Hyperglycinemia
03/2022
1Multiple System Atrophy
10/2021
1Dementia (Dementias)
10/2021
1Synucleinopathies
05/2019
1HIV Infections (HIV Infection)
05/2019
1Experimental Arthritis
10/2018
1Disease Progression
05/2017
1Alzheimer Disease (Alzheimer's Disease)
01/2016
1Renal Cell Carcinoma (Grawitz Tumor)
11/2005
1Kidney Neoplasms (Kidney Cancer)
11/2005
1Proteinuria
03/2003
1Pre-Eclampsia (Preeclampsia)
03/2003
1Hypertension (High Blood Pressure)
03/2003

Drug/Important Bio-Agent (IBA)

6Interleukin-23 (Interleukin 23)IBA
05/2024 - 04/2009
5Interleukin-12 (IL 12)IBA
05/2024 - 04/2014
3CytokinesIBA
05/2024 - 04/2009
3Peptides (Polypeptides)IBA
10/2021 - 09/2012
3RNS60IBA
01/2018 - 01/2012
2Interleukin-2 (IL2)IBA
05/2024 - 12/2023
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
03/2024 - 11/2018
2Interleukin-12 Subunit p40IBA
12/2023 - 04/2009
21- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2022 - 12/2019
2glyceryl tribenzoateIBA
03/2022 - 02/2017
2Sodium BenzoateFDA Link
03/2022 - 10/2016
2Chemokine CCL5IBA
12/2019 - 05/2019
2Myelin Basic ProteinIBA
11/2018 - 07/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2005 - 03/2003
1Biomarkers (Surrogate Marker)IBA
12/2023
1Immunomodulating AgentsIBA
01/2023
1Neuroprotective AgentsIBA
03/2022
1Food Additives (Food Additive)IBA
03/2022
1SynucleinsIBA
10/2021
1MaravirocFDA Link
05/2019
1CCR5 Receptors (CCR5 Receptor)IBA
05/2019
1Myelin ProteinsIBA
11/2018
1penetratinIBA
01/2016
1Ciliary Neurotrophic Factor (CNTF)IBA
11/2015
1PowdersIBA
01/2015
1Interleukin-7 (Interleukin 7)IBA
04/2014
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
10/2012
1Therapeutic UsesIBA
10/2012
1Peroxisome Proliferator-Activated Receptors (PPAR)IBA
10/2012
1Gemfibrozil (Lopid)FDA LinkGeneric
10/2012
1Phosphotransferases (Kinase)IBA
09/2012
1Transcription Factors (Transcription Factor)IBA
09/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2012
1Monoclonal AntibodiesIBA
04/2009
1Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
11/2005
1ElonginIBA
11/2005
1Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)IBA
03/2003
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2003

Therapy/Procedure

5Therapeutics
03/2024 - 01/2015
3Oral Administration
05/2019 - 01/2015
1Immunotherapy
12/2023
1Intranasal Administration
10/2021
1Intraperitoneal Injections
05/2017
1Immunomodulation
01/2012